Medical Condition News

RSS

Triage NGAL bedside blood test helps identify AKI risk: New study

According to a new study published last week in Intensive Care Medicine, a novel bedside blood test measured in critically ill patients being admitted to the intensive care unit can help to identify which patients are at risk for acute kidney injury (AKI). The study carried out in Vicenza, Italy, tested blood samples collected during admission to the ICU using the Triage® NGAL Test, a product currently sold by Inverness Medical Innovations, Inc. outside of the United States.

18 Dec 2009

SAIC receives multiple-award contract to support BUMED throughout the U.S.

Science Applications International Corporation (SAIC) today announced it has been awarded a prime contract by the U.S. Army Research, Development and Engineering Command Acquisition Center - Natick Contracting Division to support the U.S. Navy's Chief Bureau of Medicine and Surgery (BUMED) for Medical Research and Development, and their subordinate research and development commands.

18 Dec 2009

Cost of Avastin a deterrent for non-small-cell lung cancer treatment

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the cost of Roche/Chugai's Avastin, followed by concerns about its efficacy and side-effect profile, are cited most frequently by surveyed oncologists as the factors preventing their use of Avastin for non-small-cell lung cancer treatment in Germany, France, Italy, Spain and the United Kingdom.

18 Dec 2009

Study provides new definition on dyslexia

Contrary to popular belief, some very smart, accomplished people cannot read well. This unexpected difficulty in reading in relation to intelligence, education and professional status is called dyslexia, and researchers at Yale School of Medicine and University of California Davis, have presented new data that explain how otherwise bright and intelligent people struggle to read.

18 Dec 2009

Researchers discover how protein can be controlled and under what circumstances it can go awry

A team of researchers studying the protein that, when defective or absent, causes cystic fibrosis (CF) has made an important discovery about how that protein is normally controlled and under what circumstances it might go awry.

18 Dec 2009

A program to reduce depression and isolation among the elderly during holiday season

MyWay Village, the first senior-focused technology company to help seniors get online in an easy and social way by combining access to simplified technology with personal training and support, today announced that their Connected Living program is reducing depression and feelings of isolation especially during the holiday season within senior communities where the company's programs are being offered.

18 Dec 2009

Proprietary adult stem cell platform, an effective treatment for diabetes, shows study

Australia's regenerative medicine company, Mesoblast Limited, today announced significant preclinical trial results showing that the proprietary adult stem cell platform could be an effective treatment for diabetes.

18 Dec 2009

Pico-Tesla commences enrollment in its Magneceutical therapy study for type 2 diabetes

Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has enrolled the first seven patients for a randomized, double-blind, placebo-controlled Pilot Study of persons who have type 2 diabetes, the most common form of diabetes. The Pilot Study seeks to determine whether the application of magnetic fields generated by the Company’s patented Resonator™ system can be effective as an adjunctive therapy to oral medications in reducing hemoglobin A1c levels.

18 Dec 2009

FDA advisory committee votes against approval of Tarceva for lung cancer treatment

Yesterday, an advisory committee to the Food and Drug Administration voted against the approval of Tarceva(R) (erlotinib) as maintenance treatment for advanced lung cancer patients.

18 Dec 2009

Study findings highlight the need to develop specific health policies to address social disparities

Racial and ethnic disparities in cancer survival are greatest for cancers that can be detected early and treated successfully, including breast and prostate cancer, according to a study by researchers at Columbia University's Mailman School of Public Health and Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University Medical Center/NewYork-Presbyterian Hospital.

18 Dec 2009

Brachytherapy for lung cancer

A 58-year-old man who lives in Corona, Queens came to the emergency room of New York Hospital Queens (NYHQ) with extreme pain and tingling in his left arm. Although he did not realize it at the time, he had lung cancer. Recently, he made medical history as the first patient in the United States to be treated for lung cancer through the use of radioactive pellets placed directly in the tumor, and today his recovery is going well. Known as brachytherapy, this treatment approach is commonly used to treat prostate cancer.

18 Dec 2009

Researchers identify risk factors for major depression in elderly patients

University of Rochester Medical Center researchers have pinpointed the prime factors identifying which elderly persons are at the highest risk for developing major depression.

18 Dec 2009

Umbilical cord stem cells may be useful in treating blood disorders

Stem cells that could one day provide therapeutic options for muscle and bone disorders can be easily harvested from the tissue of the umbilical cord, just as the blood that goes through it provides precursor cells to treat some blood disorders, said University of Pittsburgh School of Medicine researchers in the online version of the Journal of Biomedicine and Biotechnology.

18 Dec 2009

BioMS Medical invests in Spectral Diagnostics to advance treatment for sepsis

Spectral Diagnostics Inc. and BioMS Medical Corp. today announced that BioMS Medical ("BioMS") and a syndicate of investors have invested $14 million in Spectral Diagnostics ("Spectral", or the "Company") to advance Toraymyxin(TM), a treatment for severe sepsis, towards regulatory approval and commercialization in the United States.

18 Dec 2009

JDRF to work with Johnson & Johnson to develop drug targets and pathways for treating diabetes

The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to speed the development of drug targets and pathways to promote the survival and function of insulin-producing cells in people who have diabetes.

18 Dec 2009

GSTM1 and GSTT1 null genotypes not associated with increased risk of GC or CRC in Koreans

The glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null genotypes have been linked to increased risk of developing cancer. The results regarding the association between GSTM1 and GSTT1 null genotypes and the risk of GC or CRC were contradictory.

18 Dec 2009

Treprostinil drug reduces breathlessness in PAH patients, says study

Patients with a rare, deadly disease that mostly affects young women felt a dramatic reduction in breathlessness using an approved drug, according to study results published online today in The Journal of Heart and Lung Transplantation.

18 Dec 2009

Ambulatory monitoring technique can disturb sleep and raise nighttime blood pressure

A widely used test for measuring nighttime blood pressure may interfere with patients' sleep, thus affecting the results of the test, reports a study in an upcoming issue of Clinical Journal of the American Society of Nephrology (CJASN).

18 Dec 2009

Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study

Researchers have developed a novel animal model showing that four commonly used chemotherapy drugs disrupt the birth of new brain cells, and that the condition could be partially reversed with the growth factor IGF-1.

18 Dec 2009

New study to examine physical activity and dietary behavior of colorectal cancer patients

In an effort to build the groundwork for future research on health promotion among individuals with colorectal and other cancers, a team of investigators at The Cancer Institute of New Jersey (CINJ) has launched a new study examining patterns in physical activity and eating habits of colorectal cancer patients who have recently finished treatment. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

18 Dec 2009

Medical Condition News

Triage NGAL bedside blood test helps identify AKI risk: New study

SAIC receives multiple-award contract to support BUMED throughout the U.S.

Cost of Avastin a deterrent for non-small-cell lung cancer treatment

Study provides new definition on dyslexia

Researchers discover how protein can be controlled and under what circumstances it can go awry

A program to reduce depression and isolation among the elderly during holiday season

Proprietary adult stem cell platform, an effective treatment for diabetes, shows study

Pico-Tesla commences enrollment in its Magneceutical therapy study for type 2 diabetes

FDA advisory committee votes against approval of Tarceva for lung cancer treatment

Study findings highlight the need to develop specific health policies to address social disparities

Brachytherapy for lung cancer

Researchers identify risk factors for major depression in elderly patients

Umbilical cord stem cells may be useful in treating blood disorders

BioMS Medical invests in Spectral Diagnostics to advance treatment for sepsis

JDRF to work with Johnson & Johnson to develop drug targets and pathways for treating diabetes

GSTM1 and GSTT1 null genotypes not associated with increased risk of GC or CRC in Koreans

Treprostinil drug reduces breathlessness in PAH patients, says study

Ambulatory monitoring technique can disturb sleep and raise nighttime blood pressure

Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study

New study to examine physical activity and dietary behavior of colorectal cancer patients

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News